What does PTEN stand for?

Protein Tyrosine Phosphatase

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Page Table Entry Low (programming) Prequalified Training Equipment List Property Tax Extension Limitation Law Public Trust Environmental Law Institute of Florida (Jacksonville, FL) Property Tax Extension Limitation Law (Illinois) Department of Physics and Technologies of Electrotechnical Materials and Components Phosphatase and Tensin Homolog Piedmont Triad Entrepreneurial Network (Greensboro, NC) Prime Time Entertainment Network (television network) Professional Tool and Equipment News (magazine; Fort Atkinson, WI)		Phenyltriethoxysilane Plasma Tetra Ethyl Oxysilane Partnership for Teacher Excellence Program (Texas) Peninsula Training and Employment Program (Australia) Personnel & Training Evaluation Program Prequalified Training Equipment Program Professional Teachers Education Program Per-Tone Equalizer Patient-Triggered Event Records (pacemaker feature) People's Trust for Endangered Species (UK)

Samples in periodicals archive:

About PTP-1B PTP-1B is a protein tyrosine phosphatase enzyme that is an important negative regulator of insulin signaling and leptin signaling.

CEPTYR BEGINS IND-ENABLING STUDIES FOR TYPE II DIABETES

This acquisition strengthens Kinetek's drug programs by adding proprietary assets and expertise for the development of protein tyrosine phosphatase inhibitors, an undeveloped therapeutic market with significant potential for treating cancer and other diseases.

Kinetek acquires Tyrogene

The abstract from the Lenocta study, titled "Phase I dose-escalation study of sodium stibogluconate (SSG), a protein tyrosine phosphatase inhibitor, combined with interferon-alfa for patients with solid tumors" (Abstract #3011), is available on the ASCO website at www.

VioQuest Pharmaceuticals Announces Upcoming Lenocta(TM) Oral ...

today announced the issuance of a second patent covering a human density enhanced protein tyrosine phosphatase known as DEP-1.

CEPTYR, Inc. Expands Its Patent Portfolio Related To DEP-1 Phosphatase

CEPTYR's mission is to use its advanced understanding of protein tyrosine phosphatases (PTPs) to discover, develop and commercialize new classes of small molecule pharmaceuticals in the following major therapy areas: immunosuppression, type II diabetes, obesity and oncology.

CEPTYR, Inc., Bothell, Wash., A Drug Discovery Company, Closes an ...